NGM Biopharmaceuticals, Inc.
NGM Biopharmaceuticals, Inc. (NGM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ngm · stock forecast · 15 analysts (3M) · FMP · updated Apr 25, 2025
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$29.00
Consensus
$16.50
+971.4% upside
Low
$4.00
Median: $16.5 · Last Close: $1.54
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$16.50
971.4% upside
High Target
$29
1783.1%
Low Target
$4
159.7%
Current Price
$1.54
as of today
Based on analyst price targets, the NGM stock price prediction for the next 12 months ranges from $4 to $29. The consensus NGM price forecast of $16.50 implies 971.4% upside from the current price of $1.54.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.54 | ↓ 0.20% |
1-day model range: $1.52–$1.55. Peak: $1.55 (-0.20%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · NGM · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-03-12 | Raymond James | Downgrade ↓ | Outperform→Market Perform |
| 2024-02-28 | TD Cowen | Downgrade ↓ | Outperform→Market Perform |
| 2023-11-22 | B. Riley Securities | Maintains | Buy→Buy |
| 2023-05-03 | Citigroup | Maintains | Buy→Buy |
| 2023-03-30 | B. Riley Securities | Maintains | Buy→Buy |
| 2023-03-29 | B. Riley Securities | Maintains | Buy→Buy |
| 2022-11-04 | Raymond James | Maintains | Outperform→Outperform |
| 2022-11-03 | Raymond James | Maintains | Outperform→Outperform |
| 2022-10-18 | Cowen & Co. | Maintains | Outperform→Outperform |
| 2022-10-18 | Raymond James | Downgrade ↓ | Strong Buy→Outperform |
Wall Street analysts have recently issued updated ratings on NGM Biopharmaceuticals, Inc. (NGM) stock. Of the recent 62 rating actions, 2 were upgrades and 13 were downgrades. 15 analysts currently cover NGM.
Analyst Recommendation Trends
NGM analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 99.6% YoY
Revenue Next Year
$0M
↑ 31.6% YoY
EPS This Year
$-1.16
EPS Next Year
$-0.87
↓ 24.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast NGM EPS of $-1.16 for the current fiscal year, based on estimates from 1 analysts. The NGM revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The NGM stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NGM price target is $16.50 (+971.4% upside), with an analyst consensus of Buy.
The NGM short-term stock prediction for tomorrow is $1.54 (-0.20%).
NGM Biopharmaceuticals, Inc. trades on NASDAQ under the ticker NGM. The NGM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
NGM forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month NGM price target is $16.50, with a high forecast of $29.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +971.4% potential upside from the current price of $1.54.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.